AAAAAA

   
Results: 1-8 |
Results: 8
THE FIRST CLINICAL PILOT-STUDY OF ROQUINIMEX (LINOMIDE(R)) IN CANCER-PATIENTS WITH SPECIAL FOCUS ON IMMUNOLOGICAL EFFECTS
Authors: BERGH JCS TOTTERMAN TH TERMANDER BC STRANDGARDEN KAMP GUNNARSSON POG NILSSON BI
Citation: Jcs. Bergh et al., THE FIRST CLINICAL PILOT-STUDY OF ROQUINIMEX (LINOMIDE(R)) IN CANCER-PATIENTS WITH SPECIAL FOCUS ON IMMUNOLOGICAL EFFECTS, Cancer investigation, 15(3), 1997, pp. 204-211
LEUKOCYTE DOUBLING TIME IS A USEFUL PREDICTOR OF PROGRESSION-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: AXDORPH U NILSSON BI NILSSON BR BJORKHOLM M
Citation: U. Axdorph et al., LEUKOCYTE DOUBLING TIME IS A USEFUL PREDICTOR OF PROGRESSION-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of internal medicine, 237(2), 1995, pp. 205-209
RELAPSE PREVENTION OF AML BY USE OF IMMUNOMODULATION ROQUINIMEX (LINOMIDE(R)) AS A POSSIBLE OPTION
Authors: NILSSON BI ROWE JM SIMONSSON B
Citation: Bi. Nilsson et al., RELAPSE PREVENTION OF AML BY USE OF IMMUNOMODULATION ROQUINIMEX (LINOMIDE(R)) AS A POSSIBLE OPTION, Experimental hematology, 23(8), 1995, pp. 932-932
ROQUINIMEX (LINOMIDE)(R) IN MYELODYSPLASTIC SYNDROME - A PHASE-II STUDY
Authors: ROSENFELD CS ZEIGLER ZR SHADDUCK RK NILSSON BI
Citation: Cs. Rosenfeld et al., ROQUINIMEX (LINOMIDE)(R) IN MYELODYSPLASTIC SYNDROME - A PHASE-II STUDY, Blood, 86(10), 1995, pp. 3187-3187
CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY ROQUINIMEX
Authors: ROWE JM RYAN DH NILSSON BI LIESVELD JL DIPERSIO JF RAPOPORT AP ABBOUD CN LARSSON L PACKMAN CH DUERST RE SIMONSSON B
Citation: Jm. Rowe et al., CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY ROQUINIMEX, Blood, 84(10), 1994, pp. 10000204-10000204
TREATMENT OF MINIMAL RESIDUAL DISEASE IN MYELOID-LEUKEMIA - THE IMMUNOTHERAPEUTIC OPTIONS WITH EMPHASIS ON LINOMIDE
Authors: ROWE JM NILSSON BI SIMONSSON B
Citation: Jm. Rowe et al., TREATMENT OF MINIMAL RESIDUAL DISEASE IN MYELOID-LEUKEMIA - THE IMMUNOTHERAPEUTIC OPTIONS WITH EMPHASIS ON LINOMIDE, Leukemia & lymphoma, 11(5-6), 1993, pp. 321-329
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH AUTOLOGOUS BONE-MARROWTRANSPLANTATION FOLLOWED BY THE IMMUNOMODULATOR ROQUINIMEX (LINOMIDE)
Authors: ROWE JM RYAN DH DIPERSIO JF NILSSON BI LARSSON L SIMONSSON B
Citation: Jm. Rowe et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH AUTOLOGOUS BONE-MARROWTRANSPLANTATION FOLLOWED BY THE IMMUNOMODULATOR ROQUINIMEX (LINOMIDE), Experimental hematology, 21(8), 1993, pp. 1020-1020
LINOMIDE(R) (ROQUINIMEX) - A NOVEL IMMUNOMODULATOR, PROSPECTS FOR PREVENTION OF RELAPSE OF ACUTE MYELOID-LEUKEMIA (AML) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: SIMONSSON B BENGTSSON M CARELLA A FERRANT A HOKLAND P NILSSON BI ROWE JW ROZMAN C TURA S TOTTERMAN T
Citation: B. Simonsson et al., LINOMIDE(R) (ROQUINIMEX) - A NOVEL IMMUNOMODULATOR, PROSPECTS FOR PREVENTION OF RELAPSE OF ACUTE MYELOID-LEUKEMIA (AML) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Experimental hematology, 21(8), 1993, pp. 1096-1096
Risultati: 1-8 |